CTI BioPharma Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2017 - 2021
Period Ending	Jun '25 Jun 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2017 - 2021
Interest Income on Loans	117,124	114,813	96,940	79,927	70,958	69,739	Upgrade
Interest Paid on Deposits	79,057	76,976	68,529	50,194	44,445	47,120	Upgrade
Net Interest Income	38,340	37,837	28,410	29,734	26,513	22,619	Upgrade
Net Interest Income Growth (YoY)	29.81%	33.18%	-4.45%	12.15%	17.21%	9.93%	Upgrade
Gain (Loss) on Sale of Assets	-1.98	-1.98	4.4	21.54	-1.58	-0.1	Upgrade
Gain (Loss) on Sale of Investments	3,746	3,746	113.91	-141.78	2,707	4,159	Upgrade
Other Non-Interest Income	14,682	11,932	12,096	9,520	6,889	4,877	Upgrade
Total Non-Interest Income	18,426	15,677	12,215	9,400	9,594	9,036	Upgrade
Non-Interest Income Growth (YoY)	49.00%	28.34%	29.95%	-2.02%	6.17%	0.69%	Upgrade
Revenues Before Loan Losses	56,767	53,513	40,625	39,133	36,107	31,655	Upgrade
Provision for Loan Losses	11,728	10,591	5,355	1,369	2,910	35,049	Upgrade
Revenue	45,039	42,922	35,270	37,764	33,197	-3,394	Upgrade
Revenue Growth (YoY)	26.00%	21.70%	-6.60%	13.76%	-	-	Upgrade
Salaries and Employee Benefits	21,520	20,885	19,442	15,444	14,786	16,881	Upgrade
Occupancy Expenses	3,289	3,289	3,197	3,160	2,835	2,621	Upgrade
Selling, General & Administrative	1,092	1,092	946.35	1,074	488.41	429.49	Upgrade
Other Non-Interest Expense	7,881	7,497	5,730	4,957	4,697	4,003	Upgrade
Total Non-Interest Expense	33,782	32,764	29,316	24,634	22,806	23,935	Upgrade
EBT Excluding Unusual Items	11,256	10,158	5,954	13,130	10,391	-27,329	Upgrade
Pretax Income	11,256	10,158	5,954	13,130	10,391	-27,329	Upgrade
Income Tax Expense	221.4	-	-	-	-	-	Upgrade
Net Income	11,035	10,158	5,954	13,130	10,391	-27,329	Upgrade
Net Income to Common	11,035	10,158	5,954	13,130	10,391	-27,329	Upgrade
Net Income Growth	76.77%	70.61%	-54.65%	26.37%	-	-	Upgrade
Basic Shares Outstanding	6,872	6,781	6,778	6,778	4,060	765	Upgrade
Diluted Shares Outstanding	6,872	6,781	6,778	6,778	4,060	765	Upgrade
Shares Change (YoY)	1.07%	0.05%	-	66.94%	430.52%	21.69%	Upgrade
EPS (Basic)	1.61	1.50	0.88	1.94	2.56	-35.71	Upgrade
EPS (Diluted)	1.61	1.50	0.88	1.94	2.56	-35.71	Upgrade
EPS Growth	74.90%	70.52%	-54.65%	-24.30%	-	-	Upgrade
Dividend Per Share	-	0.070	0.200	0.480	0.310	-	Upgrade
Dividend Growth	-	-65.00%	-58.33%	54.84%	-	-	Upgrade
Effective Tax Rate	1.97%	-	-	-	-	-	Upgrade

Updated Jan 15, 2025. Source: S&P Global Market Intelligence. Banks template. Financial Sources.